{
  "id": "digoxin_toxicity_multipleChoice_v1",
  "type": "multipleChoice",
  "stem": "A patient with heart failure taking digoxin and furosemide reports seeing 'yellow halos' around lights and feeling nauseated. Which assessment finding is most important for the nurse to verify?",
  "options": [
    {
      "id": "a",
      "text": "Serum sodium level."
    },
    {
      "id": "b",
      "text": "Serum potassium level."
    },
    {
      "id": "c",
      "text": "Daily weight change."
    },
    {
      "id": "d",
      "text": "Basilar lung crackles."
    }
  ],
  "correctOptionId": "b",
  "pedagogy": {
    "bloomLevel": "analyze",
    "cjmmStep": "analyzeCues",
    "nclexCategory": "Pharmacological and Parenteral Therapies",
    "difficulty": 3,
    "topicTags": [
      "Digoxin",
      "Potassium",
      "Pharmacology",
      "Heart Failure",
      "Electrolyte Imbalance"
    ]
  },
  "rationale": {
    "answerBreakdown": [
      {
        "optionId": "a",
        "content": "Incorrect. While furosemide can cause hyponatremia, it doesn't directly potentiate digoxin toxicity to the same extent as hypokalemia. Digoxin's toxicity primarily stems from its interaction with the Na+/K+-ATPase pump, where potassium concentration is crucial. Verifying sodium doesn't address the immediate risk of cardiac arrhythmia from digoxin toxicity. Digoxin inhibits the Na+/K+ ATPase pump, leading to increased intracellular sodium and calcium, enhancing myocardial contractility but also increasing the risk of arrhythmias. Hypokalemia exacerbates this effect by increasing digoxin binding to the pump.",
        "clinicalPearls": "Hyponatremia can contribute to general weakness and confusion, but it's not the primary concern in suspected digoxin toxicity. Focus on the electrolytes that directly influence digoxin's mechanism of action."
      },
      {
        "optionId": "b",
        "content": "Correct. The patient's symptoms (nausea, xanthopsia/'yellow halos') are classic signs of digoxin toxicity. Digoxin binds to the Na+/K+-ATPase pump in myocardial cells, competing with potassium. Furosemide, a loop diuretic, causes potassium loss (hypokalemia). Low potassium increases digoxin binding, inhibiting the pump and increasing intracellular calcium, leading to dangerous cardiac dysrhythmias. Verifying serum potassium is critical to confirm the cause and guide intervention to prevent fatal arrhythmia. Hypokalemia increases the affinity of digoxin for the Na+/K+ ATPase pump, leading to greater inhibition of the pump at lower digoxin concentrations, resulting in increased intracellular calcium and enhanced myocardial contractility, but also increasing the risk of afterdepolarizations and arrhythmias. The 'yellow halos' (xanthopsia) are thought to be due to digoxin's effects on retinal cells.",
        "clinicalPearls": "Xanthopsia is a highly specific sign of digoxin toxicity. Always consider digoxin toxicity in patients on digoxin presenting with new visual disturbances, especially if they are also on a potassium-wasting diuretic."
      },
      {
        "optionId": "c",
        "content": "Incorrect. Daily weight indicates fluid status in heart failure but doesn't address the acute medication toxicity. The symptoms point to a cellular-level problem (digoxin's effect on the myocardium), not a systemic fluid volume problem. The immediate risk is a cardiac electrical disturbance, which has a higher priority than assessing fluid balance. While fluid overload can worsen heart failure and indirectly affect electrolyte balance, it doesn't directly cause digoxin toxicity. Digoxin toxicity is primarily related to the drug's interaction with the Na+/K+ ATPase pump and is exacerbated by electrolyte imbalances, particularly hypokalemia.",
        "clinicalPearls": "While monitoring fluid balance is important in heart failure, it's not the priority when digoxin toxicity is suspected. Focus on the signs and symptoms specific to digoxin toxicity and the factors that can precipitate it."
      },
      {
        "optionId": "d",
        "content": "Incorrect. Basilar lung crackles indicate pulmonary edema from worsening left-sided heart failure. This is important for the patient's overall cardiac status. However, the patient's specific complaints of nausea and visual disturbances are hallmark signs of digoxin toxicity, not fluid overload. The acute, life-threatening risk is a fatal arrhythmia from the drug's toxic effect, which is directly exacerbated by low potassium. Addressing the potential toxicity is the immediate priority over assessing for signs of chronic disease exacerbation. Pulmonary edema results from increased pulmonary capillary wedge pressure due to left ventricular dysfunction. While this can contribute to overall cardiac instability, it doesn't directly cause or exacerbate digoxin toxicity. Digoxin toxicity is primarily related to the drug's interaction with the Na+/K+ ATPase pump.",
        "clinicalPearls": "Crackles indicate fluid overload, but in the presence of digoxin and furosemide, and the symptoms described, digoxin toxicity is the more immediate concern. Prioritize assessments and interventions accordingly."
      }
    ],
    "questionTrap": "The primary trap is choosing between assessing the patient's chronic disease (heart failure) versus an acute, iatrogenic complication (medication toxicity). Options 'c' and 'd' (weight and crackles) are correct assessments for heart failure but are not the priority when classic signs of digoxin toxicity are present. The concurrent use of furosemide is a critical cue that points directly to hypokalemia as the most probable trigger for the toxicity. The test-taker must prioritize the acute, life-threatening condition over routine disease management assessments.",
    "mnemonics": "For Digoxin Toxicity, remember 'DIGS LOW K+'\n\n- **D**ysrhythmias (bradycardia, heart block)\n- **I**ntestinal upset (nausea, vomiting, anorexia - earliest signs)\n- **G**eneral malaise (fatigue, confusion)\n- **S**ight disturbances (xanthopsia - yellow/green halos, blurred vision)\n\n- **LOW K+**: Hypokalemia is the most common electrolyte imbalance that precipitates digoxin toxicity. The lower the potassium, the higher the risk of toxicity.",
    "correct": "The correct answer is B: Serum potassium level. The patient's symptoms, combined with the use of digoxin and furosemide, strongly suggest digoxin toxicity, which is often exacerbated by hypokalemia induced by furosemide. Verifying the potassium level is the most important initial assessment to guide treatment."
  },
  "scoring": {
    "method": "dichotomous",
    "maxPoints": 1
  },
  "version": "2026",
  "sbar": {
    "situation": "0800: A patient with heart failure, on digoxin and furosemide, reports seeing 'yellow halos' around lights and feeling nauseated.",
    "background": "The patient is being treated for heart failure with digoxin and furosemide. Digoxin has a narrow therapeutic index, and furosemide can cause potassium loss, increasing the risk of digoxin toxicity. The patient's baseline potassium level is unknown.",
    "assessment": "0805: The patient is exhibiting signs and symptoms suggestive of digoxin toxicity, including visual disturbances (xanthopsia) and gastrointestinal distress (nausea). Heart rate and rhythm need to be assessed.",
    "recommendation": "0810: The nurse should immediately verify the patient's serum potassium level via lab draw and report the findings to the provider STAT. Hold the next scheduled digoxin dose pending lab results and provider orders. Be prepared to administer potassium supplementation (oral or IV) as indicated by lab results and provider orders. Continuous cardiac monitoring is recommended."
  },
  "clinicalPearl": "Always consider digoxin toxicity in patients taking digoxin and diuretics who present with new visual disturbances, gastrointestinal symptoms, or cardiac arrhythmias. Hypokalemia is a major risk factor. Early recognition and intervention are crucial to prevent life-threatening complications.",
  "sentinelStatus": "healed_v2026_v11"
}